Status:
COMPLETED
Ganglionic Local Opioid Analgesia at the Ganglion Cervicale Superius
Lead Sponsor:
Klinikum Klagenfurt am Wörthersee
Collaborating Sponsors:
University of Klagenfurt
Conditions:
Trigeminal Neuralgia, Idiopathic
Postherpetic; Neuralgia, Trigeminal (Etiology)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The blockade of the superior cervical ganglion (GCS) of the sympathetic trunk is a very special form of therapy. The transoral blocking technique, also known as GLOA (ganglionic local opioid analgesia...
Detailed Description
The blockade of the superior cervical ganglion (GCS) of the sympathetic trunk is a very special form of therapy. It is successfully used for numerous, often protracted diseases that severely impair th...
Eligibility Criteria
Inclusion
- Trigeminal neuralgia
- Postherpetic neuralgia
- Glossopharyngeal neuralgia
- Atypical facial pain
Exclusion
- psychosis
- language barrier
- Pregnant and breastfeeding women
- Seizure disorders (epilepsy)
- Increased risk of bleeding
Key Trial Info
Start Date :
January 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05257655
Start Date
January 9 2023
End Date
October 1 2023
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Klagenfurt am Wörthersee
Klagenfurt, Austria, 9020